Evidence map›Paper›PMID 27829784›Full record

ArticleMolecular vision2016

IRBP deficiency permits precocious ocular development and myopia.

Shanu Markand, Natecia L Baskin, Ranjay Chakraborty, Erica Landis, Sara A Wetzstein, Kevin J Donaldson, Priyanka Priyadarshani, Shannon E Alderson, Curran S Sidhu, Jeffrey H Boatright and 3 more

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Insights into Myopia from Mouse Models.Annual review of vision science · 2024
    Review
  6. Article
  7. Article
  8. The Role of Retinal Dysfunction in Myopia Development.Cellular and molecular neurobiology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Analysis of Damage and Wound Healing in the Retinal Pigmented Epithelium.Advances in experimental medicine and biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Shanu MarkandDepartment of Ophthalmology, Emory University, Atlanta, GA.
Natecia L BaskinDepartment of Ophthalmology, Emory University, Atlanta, GA.
Ranjay ChakrabortyDepartment of Ophthalmology, Emory University, Atlanta, GA; Atlanta Veterans Administration Center of Visual and Neurocognitive Rehabilitation, Decatur, GA.
Erica LandisAtlanta Veterans Administration Center of Visual and Neurocognitive Rehabilitation, Decatur, GA; Neuroscience Program, Laney Graduate School, Emory University, Atlanta, GA.
Sara A WetzsteinDepartment of Ophthalmology, Emory University, Atlanta, GA.
Kevin J DonaldsonDepartment of Ophthalmology, Emory University, Atlanta, GA.
Priyanka PriyadarshaniDepartment of Ophthalmology, Emory University, Atlanta, GA.
Shannon E AldersonDepartment of Ophthalmology, Emory University, Atlanta, GA.
Curran S SidhuDepartment of Ophthalmology, Emory University, Atlanta, GA.
Jeffrey H BoatrightDepartment of Ophthalmology, Emory University, Atlanta, GA; Atlanta Veterans Administration Center of Visual and Neurocognitive Rehabilitation, Decatur, GA.
P Michael IuvoneDepartment of Ophthalmology, Emory University, Atlanta, GA; Department of Pharmacology, Emory University, Atlanta, GA.
Machelle T PardueDepartment of Ophthalmology, Emory University, Atlanta, GA; Atlanta Veterans Administration Center of Visual and Neurocognitive Rehabilitation, Decatur, GA; Neuroscience Program, Laney Graduate School, Emory University, Atlanta, GA; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA.
John M NickersonDepartment of Ophthalmology, Emory University, Atlanta, GA.
Emory University · USAtlanta VA Health Care System · USGeorgia Institute of Technology · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI PARDUE, MACHELLE T. · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
Retinal Mechanisms of Refractive DevelopmentR01EY016435 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Machelle T. Pardue · 2009 to 2026
$5.4M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Oligonucleotide Repair of a Retinal Degeneration ModelR01EY014026 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 2004 to 2015
$4.1M
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)R01EY021592 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, IUVONE, P MICHAEL · 2013 to 2021
$3.3M
Gene Delivery in Retinal DiseasesR01EY016470 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 2006 to 2015
$3.2M
Deciphering the Usher I protein interactome using a genetic approachR01DC009246 · NIDCD · CASE WESTERN RESERVE UNIVERSITY · PI ZHENG, QING Y · 2009 to 2013
$1.6M
Bridging animal and human models of exercise-induced visual rehabilitationI21RX001924 · VA · VETERANS HEALTH ADMINISTRATION · PI BOATRIGHT, JEFFREY H · 2015 to 2017
–
NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01 EY014026NEI NIH HHS R01 EY016435NEI NIH HHS R01 EY016470NEI NIH HHS R01 EY021592NEI NIH HHS T32 EY007092NIDCD NIH HHS R01 DC009246RRD VA I21 RX001924
6 · The paper itself

Abstract

purposeInterphotoreceptor retinoid-binding protein (IRBP) is abundant in the subretinal space and binds retinoids and lipophilic molecules. The expression of IRBP begins precociously early in mouse eye development. IRBP-deficient (KO) mice show less cell death in the inner retinal layers of the retina before eyelid opening compared to wild-type C57BL/6J (WT) controls and eventually develop profound myopia. Thus, IRBP may play a role in eye development before visually-driven phenomena. We report comparative observations during the course of the natural development of eyes in WT and congenic IRBP KO mice that suggest IRBP is necessary at the early stages of mouse eye development for correct function and development to exist in later stages.

methodsWe observed the natural development of congenic WT and IRBP KO mice, monitoring several markers of eye size and development, including haze and clarity of optical components in the eye, eye size, axial length, immunohistological markers of differentiation and eye development, visually guided behavior, and levels of a putative eye growth stop signal, dopamine. We conducted these measurements at several ages. Slit-lamp examinations were conducted at post-natal day (P)21. Fundus and spectral domain optical coherence tomography (SD-OCT) images were compared at P15, P30, P45, and P80. Enucleated eyes from P5 to P10 were measured for weight, and ocular dimensions were measured with a noncontact light-emitting diode (LED) micrometer. We counted the cells that expressed tyrosine hydroxylase (TH-positive cells) at P23-P36 using immunohistochemistry on retinal flatmounts. High-performance liquid chromatography (HPLC) was used to analyze the amounts of dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) at P7-P60. Monocular form deprivation in the right eye was induced using head-mounted goggles from P28 to P56.

resultsEye elongation and eye size in the IRBP KO mice began to increase at P7 compared to the WT mice. This difference increased until P12, and the difference was maintained thereafter. SD-OCT images in live mice confirmed previously reported retinal thinning of the outer nuclear layer in the IRBP KO mice compared to the WT mice from P15 to P80. Slit-lamp and fundoscopy examination outcomes did not differ between the WT and KO mice. SD-OCT measurements of the optical axis components showed that the only factor contributing to excess optical axis length was the depth of the vitreous body. No other component of optical axis length (including corneal thickness, anterior chamber depth, and lens thickness) was different from that of the WT mouse. The refractive power of the IRBP KO mice did not change in response to form deprivation. The number of retinal TH-positive cells was 28% greater in the IRBP KO retinas compared to the WT mice at P30. No significant differences were observed in the steady-state retinal DA or DOPAC levels or in the DOPAC/DA ratios between the WT and IRBP KO mice.

conclusionsThe IRBP KO mouse eye underwent precocious development and rapid eye size growth temporally about a day sooner than the WT mouse eye. Eye size began to differ between the WT and KO mice before eyelid opening, indicating no requirement for focus-dependent vision, and suggesting a developmental abnormality in the IRBP KO mouse eye that precedes form vision-dependent emmetropization. Additionally, the profoundly myopic KO eye did not respond to form deprivation compared to the non-deprived contralateral eye. Too much growth occurred in some parts of the eye, possibly upsetting a balance among size, differentiation, and focus-dependent growth suppression. Thus, the loss of IRBP may simply cause growth that is too rapid, possibly due to a lack of sequestration or buffering of morphogens that normally would bind to IRBP but are unbound in the IRBP KO eye. Despite the development of profound myopia, the DA levels in the IRBP KO mice were not statistically different from those in the WT mice, even with the excess of TH-positive cells in the IRBP KO mice compared to the WT mice. Overall, these data suggest that abnormal eye elongation in the IRBP KO mouse is independent of, precedes, and is epistatic to the process(es) of visually-driven refractive development.

Indexed as

3,4-Dihydroxyphenylacetic AcidAnimalsAxial Length, EyeDisease Models, AnimalDopamineEyeEye ProteinsMiceMice, Inbred C57BLMice, KnockoutMyopiaRetinaRetinol-Binding ProteinsRetinol-Binding Proteins, InterstitialTomography, Optical Coherence3,4-Dihydroxyphenylacetic AcidDopamineEye ProteinsRetinol-Binding ProteinsRetinol-Binding Proteins, Interstitial

Identifiers

PMID27829784
PMCPMC5082647
OpenAlexW2546067451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.